UBS analyst AJ Rice upgraded Universal Health to Buy from Neutral with a price target of $226, up from $189. The firm has enhanced visibility into upside to the company’s earnings given recent supplemental payment developments, as well as improving operational results. Universal Health’s behavioral segment was hit particularly hard by the pandemic and the resulting labor shortage, which caused several years of below average patient day growth, the analyst tells investors in a research note. Now that the labor market has stabilized, the company is positioned to increase staffing capacity to meet the growing demand for behavioral health services, contends UBS.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
- Universal Health price target raised to $189 from $183 at RBC Capital
- Universal Health price target raised to $183 from $181 at TD Cowen
- Universal Health price target raised to $189 from $181 at Barclays
- Universal Health reports Q1 adjusted EPS $3.70 vs. $2.34 last year